학술논문

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
Document Type
Article
Source
In: Gynecologic Oncology. (Gynecologic Oncology, March 2024, 182:75-81)
Subject
Language
English
ISSN
10956859
00908258